Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?
The inherent instability of proteins when isolated from their native conditions creates the necessity of suitable stabilisation techniques. Because of the instability of proteins in solution it is often necessary to produce them as solid formulations. A method of producing relatively stable, solid protein pharmaceuticals is to incorporate them with a suitable excipient into an amorphous matrix by dehydration. The use of spray dried multiple excipient/single protein blends was compared to single excipient/protein systems using lysozyme as a model protein to establish the stabilising ability of such systems. Unprocessed controls and spray dried samples were characterised structurally by X-ray powder diffraction and Fourier transform Raman spectroscopy and also thermally by differential scanning calorimetry and thermogravimetric analysis. Retained lysozyme activity was assayed enzymatically. To assess long-term stability, samples were subjected to conditions of elevated temperature and relative humidity (RH) 40 degrees C/75% RH. Structural and thermal analysis of samples revealed that mannitol/trehalose spray dried excipient/lysozyme blends were completely amorphous upon production but partially recrystallised upon storage at elevated temperature and RH. Biological activity assays revealed that samples containing trehalose retained the highest percentage activity. Under the conditions employed mannitol/trehalose systems stabilise lysozyme more effectively than single excipient systems due to their ability to form amorphous products.
Hulse
Wendy L
WL
Drug Delivery Group, School of Pharmacy, University of Bradford, Richmond Road, Bradford BD7 1DP, UK.
Forbes
Robert T
RT
Bonner
Michael C
MC
Getrost
Matthias
M
D002152:Calorimetry, Differential Scanning; D004339:Drug Compounding; D004355:Drug Stability; D005079:Excipients / Q000737:chemistry* / Q000494:pharmacology; D008353:Mannitol / Q000737:chemistry* / Q000494:pharmacology; D008837:Micrococcus / Q000187:drug effects; D009113:Muramidase / Q000737:chemistry* / Q000494:pharmacology; D013012:Sorbitol / Q000737:chemistry* / Q000494:pharmacology; D013818:Thermogravimetry; D014199:Trehalose / Q000737:chemistry* / Q000494:pharmacology; D014961:X-Ray Diffraction
D005079:Excipients; D008353:Mannitol; D013012:Sorbitol; D014199:Trehalose; D009113:Muramidase